These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15450267)

  • 21. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer screening.
    Natl Inst Health Consens Dev Conf Summ; 1977-1978; 1():5-8. PubMed ID: 400924
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Photofluorography and breast cancer. Contribution to the mammography controversy].
    Strasser E; Friedl HP
    Rontgenpraxis; 1983 Jul; 36(7):232-6. PubMed ID: 6623207
    [No Abstract]   [Full Text] [Related]  

  • 27. Mammography screening in women 40 to 49 years old.
    Léger MM; McNellis R;
    JAAPA; 2007 Nov; 20(11):16, 18. PubMed ID: 18035758
    [No Abstract]   [Full Text] [Related]  

  • 28. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there downsides to mammography screening?
    Baines CJ
    Breast J; 2005; 11 Suppl 1():S7-10. PubMed ID: 15725116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography and the value of screening.
    Whitehouse GH
    Br J Hosp Med; 1985 Nov; 34(5):263. PubMed ID: 3836718
    [No Abstract]   [Full Text] [Related]  

  • 31. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark.
    Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Recent trends in breast cancer among younger women in the United States.
    Tarone RE
    J Natl Cancer Inst; 2009 May; 101(9):691-2; author reply 692-3. PubMed ID: 19401551
    [No Abstract]   [Full Text] [Related]  

  • 34. ACS--NCI breast cancer detection demonstration projects--opening of the Nashville project.
    Byrd BF
    J Tenn Med Assoc; 1975 Apr; 68(4):287-8. PubMed ID: 1117717
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast cancer screening recommendations: dynamic extrapolation of limited data.
    Mooney C; Merajver S
    Breast Cancer Res Treat; 2010 May; 121(1):143-6. PubMed ID: 20063195
    [No Abstract]   [Full Text] [Related]  

  • 36. Some current issues in breast cancer screening.
    Duffy SW
    J Med Screen; 2005; 12(3):128-33. PubMed ID: 16156943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer facts: a look at mammography.
    Bertrand ML; Heater K; Jenkins C
    N C Med J; 1987 Oct; 48(10):507-9. PubMed ID: 3479691
    [No Abstract]   [Full Text] [Related]  

  • 39. When is breast magnetic resonance imaging recommended for cancer detection?
    Miller JC; Rafferty EA; Specht MC; Thrall JH; Lee SI
    J Am Coll Radiol; 2008 Mar; 5(3):224-6. PubMed ID: 18312973
    [No Abstract]   [Full Text] [Related]  

  • 40. [The balance between health gains and effort exerted in population screening for breast cancer].
    van Dijck JA
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1230. PubMed ID: 9627462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.